Clinical Trials on 手术条件 in Finland
总计9385个结果
-
AstraZeneca终止Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC芬兰
-
Merja NikulaHelsinki University Central Hospital; University of Helsinki; University of Oulu; Aalto University招聘中
-
Helsinki University Central Hospital完全的
-
MedImmune LLCWyeth is now a wholly owned subsidiary of Pfizer完全的
-
Hanna Savolainen-PeltonenUniversity of Southern California招聘中
-
Tampere University Hospital完全的
-
Turku University Hospital完全的
-
Kuopio University HospitalUniversity of Eastern Finland完全的
-
South Karelia, Social and Health Care District完全的
-
Pia Osterlund招聘中
-
University of OuluGlaxoSmithKline; Oulu University Hospital; Foundation of the Finnish Anti-Tuberculosis Association 和其他合作者完全的
-
University of HelsinkiUniversity of Turku; Tampere University Hospital; Finnish Institute for Health and Welfare完全的
-
Turku University HospitalUniversity of Turku完全的
-
Turku University Hospital招聘中
-
Turku University HospitalUniversity of Turku; Lund University Hospital完全的
-
Helsinki University Central HospitalMedtronic International Trading Sarl招聘中
-
Central Finland Hospital DistrictUniversity of Jyvaskyla; Finnish Diabetes Association完全的
-
Folkhälsan Researech CenterNärpes Health Care Center, Närpes, Finland; Department of Social Services and Health Care, Jakobstad... 和其他合作者完全的
-
Turku University HospitalUniversity of Turku; University of Helsinki; Academy of Finland; European Foundation for the Study... 和其他合作者未知